SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-001099
Filing Date
2022-01-18
Accepted
2022-01-18 16:23:04
Documents
15
Period of Report
2022-01-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20220117_8k.htm   iXBRL 8-K 29345
2 EXHIBIT 5.1 ex_324712.htm EX-5.1 17910
7 logo.jpg GRAPHIC 9817
  Complete submission text file 0001437749-22-001099.txt   192859

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA stab-20220112.xsd EX-101.SCH 3594
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20220112_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20220112_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20220112_pre.xml EX-101.PRE 11585
9 EXTRACTED XBRL INSTANCE DOCUMENT cbli20220117_8k_htm.xml XML 2569
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 22535454
SIC: 2834 Pharmaceutical Preparations